[HTML][HTML] Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
AL Degraeve, V Haufroid, A Loriot, L Gatto, V Andries… - Microbiome, 2023 - Springer
Background Following solid organ transplantation, tacrolimus (TAC) is an essential drug in
the immunosuppressive strategy. Its use constitutes a challenge due to its narrow …
the immunosuppressive strategy. Its use constitutes a challenge due to its narrow …
ABC transporters: An overview
LM Koehn - The ADME encyclopedia: a comprehensive guide on …, 2022 - Springer
Adenosine-triphosphate binding cassette transporters, otherwise known as ABC
transporters, play a major role in drug pharmacokinetics. They are membrane-bound …
transporters, play a major role in drug pharmacokinetics. They are membrane-bound …
Application of a human intestinal epithelial cell monolayer to the prediction of oral drug absorption in humans as a superior alternative to the Caco-2 cell monolayer
T Takenaka, N Harada, J Kuze, M Chiba, T Iwao… - Journal of …, 2016 - Elsevier
A human small intestinal epithelial cell (HIEC) monolayer was recently established in our
laboratories as a novel system to evaluate the P app (apparent permeability coefficient) of …
laboratories as a novel system to evaluate the P app (apparent permeability coefficient) of …
Evaluation of the Herb–Drug Interaction (HDI) Potential of Zingiber officinale and Its Major Phytoconstituents
Ginger is currently one of the most popular herbs commonly added to diverse foods,
beverages, and dietary supplements. We evaluated the ability of a well-characterized ginger …
beverages, and dietary supplements. We evaluated the ability of a well-characterized ginger …
The impact of breast cancer resistance protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers
I Kawahara, S Nishikawa, A Yamamoto, Y Kono… - Drug Metabolism and …, 2020 - ASPET
Breast cancer resistance protein (BCRP) is expressed on the apical membrane of small
intestinal epithelial cells and functions as an efflux pump with broad substrate recognition …
intestinal epithelial cells and functions as an efflux pump with broad substrate recognition …
[HTML][HTML] Dual inhibition of P-gp and BCRP improves oral topotecan bioavailability in rodents
J Lee, J Kang, NY Kwon, A Sivaraman, R Naik, SY Jin… - Pharmaceutics, 2021 - mdpi.com
P-glycoprotein (P-gp) inhibition has been studied to overcome multidrug resistance in
cancer chemotherapy but failed in clinical trials due to low/toxic effects. Recently, a dual …
cancer chemotherapy but failed in clinical trials due to low/toxic effects. Recently, a dual …
Construction of extended and functional bile canaliculi using long-term sandwich-cultured cryopreserved human hepatocytes and the application of hepatocytes for …
T Kitaguchi, S Horiuchi, Y Kuroda, K Ohno… - The Journal of …, 2023 - jstage.jst.go.jp
The biliary excretion of pharmaceutical and food-related compounds is an important factor
for assessing pharmacokinetics and toxicities in humans, and a highly predictive in vitro …
for assessing pharmacokinetics and toxicities in humans, and a highly predictive in vitro …
Modulation of intestinal transport and absorption of topotecan, a BCRP substrate, by various pharmaceutical excipients and their inhibitory mechanisms of BCRP …
K Sawangrat, S Yamashita, A Tanaka… - Journal of …, 2019 - Elsevier
Breast cancer resistance protein transporter (ABCG2/BCRP) is highly expressed on the
intestinal epithelial membrane and has a significant impact on the oral absorption of …
intestinal epithelial membrane and has a significant impact on the oral absorption of …
Pharmacokinetics of mangiferin and its metabolite—norathyriol, Part 2: Influence of UGT, CYP450, P‐gp, and enterobacteria and the potential interaction in Rhizoma …
X Tian, Z Xu, Z Li, Y Ma, S Lian, X Guo, P Hu, Y Gao… - Biofactors, 2016 - Wiley Online Library
The poor bioavailability of mangiferin (MGF) is a major obstacle on its further development.
Aimed to illustrate the underlying mechanism and improve its poor exposure, the compared …
Aimed to illustrate the underlying mechanism and improve its poor exposure, the compared …
[HTML][HTML] Characterization of P-glycoprotein inhibitors for evaluating the effect of P-glycoprotein on the intestinal absorption of drugs
Y Kono, I Kawahara, K Shinozaki, I Nomura… - Pharmaceutics, 2021 - mdpi.com
For developing oral drugs, it is necessary to predict the oral absorption of new chemical
entities accurately. However, it is difficult because of the involvement of efflux transporters …
entities accurately. However, it is difficult because of the involvement of efflux transporters …